These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14497067)

  • 21. Antibody responses to British poliomyelitis vaccine of children with naturally occurring antibody.
    RUSSELL K
    Br Med J; 1958 Mar; 1(5071):622-4. PubMed ID: 13510748
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antibody response of the infant to antipoliomyelitic vaccine].
    MORRONE G; NUNZIATA B; PICCIOTTO L; BRANCATO P
    Riv Ist Sieroter Ital; 1960; 35():590-602. PubMed ID: 13772898
    [No Abstract]   [Full Text] [Related]  

  • 23. [ACTION OF SOME ANTIBIOTICS ON PRODUCTION OF ANTI-INFLUENZA ANTIBODIES IN THE MOUSE].
    MALANDRINI F; PIERI I; VEDOVINI F
    Atti Accad Fisiocrit Siena Med Fis; 1963; 12():311-6. PubMed ID: 14314821
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization].
    MORRONE G; NUNZIATA B
    Pediatria (Napoli); 1961; 69():851-6. PubMed ID: 14476315
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation.
    SALK JE; BAZELEY PL; BENNETT BL; KRECH U; LEWIS LJ; WARD EN; YOUNGNER JS
    Am J Public Health Nations Health; 1954 Aug; 44(8):994-1009. PubMed ID: 13180761
    [No Abstract]   [Full Text] [Related]  

  • 26. [ON INHIBITION OF ANTIBODY FORMATION BY CORTICOSTEROIDS AND CYTOSTATICS. (I)].
    FRENGER W; WOLLENSAK J; HENNING N; EL-HASSAN A
    Med Welt; 1965 Apr; 17():920-4 CONTD. PubMed ID: 14293909
    [No Abstract]   [Full Text] [Related]  

  • 27. [ANTIBIOTICS OF ANIMAL ORIGIN IN MECHANISMS OF IMMUNOGENIC PROTECTION].
    MIKLASHEVSKII VE
    Usp Sovrem Biol; 1964; 58():100-12. PubMed ID: 14238401
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenicity, in children, of ultraviolet-treated poliomyelitis vaccine.
    WOLF AM; SHAUGHNESSY HJ; CHURCH RE; MILZER A; JANOTA M; OPPENHEIMER F; MORRISSEY RA; NAFTULIN H; CHAPMAN JW; LEVINSON SO
    J Am Med Assoc; 1956 Jun; 161(9):775-81. PubMed ID: 13319005
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vaccines and antibiotics in the treatment of acute diseases of the lung].
    MINET J
    Vie Med; 1952 Dec; 33(Spec No):91. PubMed ID: 13029397
    [No Abstract]   [Full Text] [Related]  

  • 30. [Planning of brucellosis therapy with the association of antibiotics with vaccine].
    BALDUINI M
    Gazz Med Ital; 1951 Jan; 110(1):8-14. PubMed ID: 14823259
    [No Abstract]   [Full Text] [Related]  

  • 31. [Oral vaccines and antibiotics].
    LEONARD L
    Acta Belg Arte Med Pharm Mil; 1959 Dec; 112():583-92. PubMed ID: 13760927
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of antibiotics on immunity. III. Effect of dihydrostreptomycin on antibody production in relation to a special antigen].
    FARHI A; LAMENSANS A
    C R Hebd Seances Acad Sci; 1956 Jan; 242(1):206-7. PubMed ID: 13305011
    [No Abstract]   [Full Text] [Related]  

  • 33. [DETECTION OF ANTIBIOTICS IN VARIOUS TYPES OF FOOD ON SALE IN THE ROMAN MARKETS].
    D ARCASIMONETTI A; D ARCA SU
    Nuovi Ann Ig Microbiol; 1963; 14():460-7. PubMed ID: 14128442
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the antibody response to basic immunizing treatment carried out with 2 or 3 injections of antipoliomyelitic vaccine (Salk type)].
    SANTOPADRE G; CASAROSA S; RUSCHI A; ZERBONI R
    Riv Ital Ig; 1961; 21():192-204. PubMed ID: 14497064
    [No Abstract]   [Full Text] [Related]  

  • 35. Humoral antibody immunity and cellular refractoriness in poliomyelitis. The immunizing biological plurivalent effects produced by Salvioli's antitubercular spreading vaccine (V.D.S.).
    SALVIOLI G
    Panminerva Med; 1960 Jun; 2():280-5. PubMed ID: 13858619
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of filtration procedures on immunogenic activity and safety of formalinized poliomyelitis vaccine (Salk type).
    GOLDBLUM N; MERCADO A; FOGEL A; CYMBALISTA S
    Proc Soc Exp Biol Med; 1959 Feb; 100(2):276-9. PubMed ID: 13634110
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunogenicity of poliomyelitis vaccine prepared with ultraviolet irradiation and mild heat.
    SHAUGHNESSY HJ; WOLF AM; JANOTA M; NEAL J; OPPENHEIMER F; MILZER A; NAFTULIN H; MORRISSEY RA
    Proc Soc Exp Biol Med; 1957 Jun; 95(2):251-5. PubMed ID: 13441701
    [No Abstract]   [Full Text] [Related]  

  • 38. [ISOLATION, FROM APENNINES SOILS, OF ORGANISMS PRODUCING ANTIBIOTICS AGAINST VARIOUS STRAINS OF RHIZOBIUM].
    WIERINGA KT
    Ann Inst Pasteur (Paris); 1963 Aug; 105():417-25. PubMed ID: 14048733
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of pulmonary abscess with associated antibiotics and endobronchial administration of auto-vaccine].
    GRENIER J; COLLIN P; LUTIER F
    Sem Hop; 1953 May; 29(33):1673-9. PubMed ID: 13076437
    [No Abstract]   [Full Text] [Related]  

  • 40. [FORMATION OF ANTIBODIES BY SPLEEN GRAFTS UNDER THE INFLUENCE OF ANTIBIOTICS].
    CHUMACHENKO NV; SOKOLOVA EM
    Antibiotiki; 1963 Jul; 8():601-4. PubMed ID: 14090359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.